Lennart Minthon (Former)
91 – 100 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Mild versus Moderate Stage of Alzheimer’s Disease—Three-year Outcomes of Cholinesterase Inhibitor Therapy in a Routine Clinical Setting.
- Contribution to conference › Abstract
-
Mark
Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.
- Contribution to journal › Article
-
Mark
Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.
- Contribution to journal › Article
-
Mark
Plasma tau levels in Alzheimer's disease
- Contribution to journal › Letter
-
Mark
NG2 cells, a new trail for Alzheimer's disease mechanisms?
- Contribution to journal › Article
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
- Contribution to journal › Article
-
Mark
Modern demensvård på gång tack vare nationella riktlinjer
- Contribution to journal › Article
-
Mark
Evaluation of Systolic and Diastolic Hypotension in Dementia with Lewy Bodies and Alzheimer’s Disease.
- Contribution to journal › Article
-
Mark
Diagnostic Power of 24S-Hydroxycholesterol in Cerebrospinal Fluid: Candidate Marker of Brain Health
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
- Contribution to journal › Article
